Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lepu Biotech reigns in $131mm via Series A round

Executive Summary

Lepu Biotechnology Co. Ltd. (immuno-oncology division of Lepu Medical Technology (Beijing) Co. Ltd.) raised $131mm through its Series A round from investors including Shiyu Capital (lead), Suzhou Mingtou, Sumin Investment, China Development Bank, Suzhou Shareate Group, and the company's parent Lepu Medical.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies